TP53 mutation as predictive factor of platinum response in BRCA-mutated ovarian cancer: A prospective case-series analysis.

Authors

Eleonora Lai

Eleonora Lai

Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy

Eleonora Lai , Manuela Neri , Elisabetta Sanna , Sonia Nemolato , Fabio Bardanzellu , Mario Scartozzi , Sabrina Giglio , Antonio Macciò , Clelia Madeddu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Breakthrough

Session Type

Poster Session

Session Title

Poster Session B

Track

Thoracic Cancers,Breast Cancer,Gynecologic Cancer,Head and Neck Cancer,Hematologic Malignancies,Genetics/Genomics/Multiomics,Healthtech Innovations,Models of Care and Care Delivery,Viral-Mediated Malignancies,Other Malignancies or Topics

Sub Track

Other Therapeutic Interventions

Citation

J Clin Oncol 42, 2024 (suppl 23; abstr 128)

DOI

10.1200/JCO.2024.42.23_suppl.128

Abstract #

128

Poster Bd #

D4

Abstract Disclosures